Fiat Chrysler recalling 1.1 million vehicles due to transmission shifter problem
In a Friday announcement, Fiat Chrysler said that it is recalling nearly 1.1 million vehicles due to a transmission shifter issue. The automaker said that the problem which has resulted in the recall can cause the affected vehicles to roll away unexpectedly, thereby posing a potential risk of injury.
The recall announced by Fiat Chrysler affects nearly 811,590 cars and SUVs in the US; and around 300,000 vehicles in Canada, Mexico, and other international markets. The transmission shifter problem leading to the recall has reportedly caused 41 injuries in the US.
The vehicles affected by the recall include Dodge Charger and Chrysler 300 sedans from model years 2012 to 2014; and Jeep Grand Cherokee SUVs from model years 2014 and 2015.
About the issue prompting Fiat Chrysler to announce the latest recall, the National Highway Traffic Safety Administration (NHTSA) documents have revealed that the transmission shifters in the under-recall vehicles are unreasonably difficult to operate.
In the documents, the NHTSA specifically said about the transmission issue affecting the recalled Fiat Chrysler vehicles: "The shifter is not intuitive and provides poor tactile and visual feedback to the driver, increasing the potential for unintended gear selection."
American aviation major Boeing has signaled its intent to unveil a modified version of its 737 MAX 10 aircraft at the opening of the Paris Airshow on Monday this week.
The odd dual-screen device called the YotaPhone 3 has been officially announced in the East Asian country of China for 2017 release.
After successfully launching its first X-ray space telescope, China is now preparing to launch four more space probes before 2021 as part of the ongoing efforts to develop space science.
The European Union (EU) is reportedly preparing to impose a record-high fine on tech giant Google (Alphabet) within the next few weeks, according to a WSJ report.
The U.S. Food & Drug Administration (FDA) has finally approved a new epinephrine injector for anaphylaxis, increasing competition for the controversially expensive injector EpiPen.
CenturyLink stock suffered major setback after Bloomberg published a report citing a former CenturyLink employee claiming that she was fired after she reported about fraud billing practices in the company.